Global Neurodiagnostics Market

Neurodiagnostics Market Size, Share, Growth Analysis, By Condition(Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders), By End User(Hospitals & Surgery Centers, Diagnostic Laboratories & Imaging Centers, Neurology Centers, and Others), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35D2139 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 67 | Figures: 75

Neurodiagnostics Market Dynamics

Neurodiagnostics Market Drivers

Increased Incidence of Neurological Disorders 

  • The main reason for market growth in neurodiagnostic is the mounting incidence of neurological conditions such as epilepsy, Parkinson's, and Alzheimer's. Neurodiagnostic technologies are increasingly being adopted in healthcare facilities as the demand for sophisticated diagnostic instrumentation to identify and track these disorders increases with the increased number of afflicted individuals. 

Advancement of Neurodiagnostic Technology 

  • Ongoing advancements in neurodiagnostic technologies, such as genetic testing, AI-driven diagnostics, and functional imaging approaches, are improving the accuracy and efficiency of neurological disease detection. These developments are making neurodiagnostic more accurate and dependable, thereby propelling market expansion by enabling early identification and individualized treatment alternatives. 

Neurodiagnostics Market Restraints  

Stringent Government Regulations 

  • One of the biggest challenges is the strict regulations related to the clearance and marketing of neurodiagnostic devices. Long processes and complex rules can obstruct innovation and delay the introduction of new technologies to the market, which will impede the overall growth of the neurodiagnostic market, particularly in countries with severe healthcare legislation. 

Low Demand in Underdeveloped Countries 

  • Neurodiagnostic services remain low in demand due to issues, such as poor health infrastructure, ignorance, and high cost of advanced diagnosis apparatus, in many developing countries. This remains a major limitation towards intensive global market growth since the market expands only to a much lesser extent in these regions. 
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Neurodiagnostics Market size was valued at USD 7.45 billion in 2022 and is poised to grow from USD 7.97 billion in 2023 to USD 13.70 billion by 2031, growing at a CAGR of 7% during the forecast period (2024-2031).

Some of the key players in the neurodiagnostic market include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Abbott Laboratories, and new entrants, who are predicted to be future leaders in the industry and are utilizing advanced technologies. These companies focus on strengthening their presence in the above market primarily by forming strategic alliances, mergers and acquisitions and by new product development. This is being pushed forward within healthcare organizations as artificial intelligence, imaging and genetic testing technologies evolve where organizations are looking for more precise, cheaper and quicker ways of diagnosing patients.  'Siemens Healthineers (Germany)', 'GE Healthcare (US)', 'Philips Healthcare (Netherlands)', 'Medtronic (Ireland)', 'Hitachi Medical Corporation (Japan)', 'Natus Medical Incorporated (US)', 'Abbott Laboratories (US)', 'Koninklijke Philips N.V. (Netherlands)', 'Thermo Fisher Scientific Inc. (US)', 'Elekta AB (Sweden)', 'Brainlab AG (Germany)', 'Masimo Corporation (US)', 'Cadwell Industries Inc. (US)', 'Advanced Brain Monitoring, Inc. (US)', 'Compumedics Limited (Australia)', 'Neurosoft Ltd. (Russia)', 'Magstim (UK)', 'NeuroWave Systems Inc. (US)', 'BrainScope Company Inc. (US)', 'Blackrock Microsystems LLC (US)'

The main reason for market growth in neurodiagnostic is the mounting incidence of neurological conditions such as epilepsy, Parkinson's, and Alzheimer's. Neurodiagnostic technologies are increasingly being adopted in healthcare facilities as the demand for sophisticated diagnostic instrumentation to identify and track these disorders increases with the increased number of afflicted individuals. 

Genomics and Personalized Medicine: The proteomics and genomics revolution, which is aiding the healing of neurological disorders, is the current market trend in personalization medicine. By examining an individual’s genetic code, the physician can provide more targeted and efficacious treatments enhancing that individual’s care. Therefore, this trend in the neurodiagnostic sector is leaning towards the utilization of sophisticated diagnostic techniques. 

Revenue share of the market in 2023 was occupied by North America with a dominating share of 35.8%. Many factors, such as a mature healthcare infrastructure, research and development initiatives, and health expenditures, contribute to this regional dominance. For instance, the 159-bed Indiana NeuroDiagnostic Institute and Advanced Treatment Center, NDI, which costs USD 120 million, opened in March 2019. Traumatic brain injury, neurodegenerative disorders such as Alzheimer's disease, acute and chronic mental illness, among others, are treated by the institution. Neurological conditions also happen to be relatively prevalent in the region; therefore, the more pressing need for neurodiagnostic arises.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Neurodiagnostics Market

Report ID: SQMIG35D2139

$5,300
BUY NOW GET FREE SAMPLE